Platelet adherence to cultured vascular cells: influence of prostacyclin (PGI2). 1980

G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft

UI MeSH Term Description Entries
D007651 Keto Acids Carboxylic acids that contain a KETONE group. Oxo Acids,Oxoacids,Acids, Keto,Acids, Oxo
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D011463 Prostaglandins H A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell

Related Publications

G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
March 1980, Laboratory investigation; a journal of technical methods and pathology,
G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
April 1980, Prostaglandins and medicine,
G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
August 1985, European journal of pharmacology,
G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
February 1983, Prostaglandins,
G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
July 1978, Prostaglandins,
G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
September 1980, Thrombosis research,
G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
January 1983, Intensive care medicine,
G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
October 1982, Biochemical pharmacology,
G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
January 1983, Prostaglandins, leukotrienes, and medicine,
G L Fry, and R L Czervionke, and J C Hoak, and J B Smith, and D L Haycraft
July 1980, Polskie Archiwum Medycyny Wewnetrznej,
Copied contents to your clipboard!